We were all addicted to the transparency of Nader
Post# of 150221
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
Looks like we will be like other stocks now with quarterly or biannually updates and only SEC filings. Going to be a little less chatting on the boards. Half the people will fall off the boards now with nothing to really talk about. No news will mean less to chat about.
I still believe in Leronlimab and will not sell a share. As Scott Kelly said… commercialization of our platform drug with a new CEO. Funny how the new board was the coop. It will be interesting to see if partnership / buy-out or new CEO first.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)